GENIX PHARMACEUTICALS CORP(TSX-V:GENX) stock Fundamental Analysis

Fundamental Rating

Taking everything into account, GENX scores 1 out of 10 in our fundamental rating. GENX was compared to 3 industry peers in the Personal Care Products industry. Both the profitability and financial health of GENX have multiple concerns. GENX is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

GENX had negative earnings in the past year.

In the past year GENX has reported a negative cash flow from operations.

In the past 5 years GENX always reported negative net income.

GENX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

GENX's Return On Assets of -160.53% is on the low side compared to the rest of the industry. GENX is outperformed by 66.67% of its industry peers.

		Industry Rank	Sector Rank
ROA	-160.53%
ROE	N/A
ROIC	N/A

ROA(3y)-717.5%

ROA(5y)-440.12%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

GENX has a Gross Margin of 31.71%. This is in the better half of the industry: GENX outperforms 66.67% of its industry peers.

The Profit Margin and Operating Margin are not available for GENX so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	31.71%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

GENX does not have a ROIC to compare to the WACC, probably because it is not profitable.

GENX has about the same amout of shares outstanding than it did 1 year ago.

GENX has more shares outstanding than it did 5 years ago.

The debt/assets ratio for GENX is higher compared to a year ago.

2.2 Solvency

GENX has an Altman-Z score of -382.04. This is a bad value and indicates that GENX is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -382.04, GENX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-382.04

ROIC/WACCN/A

WACC6.12%

2.3 Liquidity

A Current Ratio of 0.03 indicates that GENX may have some problems paying its short term obligations.

GENX's Current ratio of 0.03 is on the low side compared to the rest of the industry. GENX is outperformed by 66.67% of its industry peers.

A Quick Ratio of 0.03 indicates that GENX may have some problems paying its short term obligations.

Looking at the Quick ratio, with a value of 0.03, GENX is doing worse than 66.67% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	0.03
Quick Ratio	0.03

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

GENX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 98.38%, which is quite impressive.

Looking at the last year, GENX shows a very negative growth in Revenue. The Revenue has decreased by -66.94% in the last year.

Measured over the past years, GENX shows a very negative growth in Revenue. The Revenue has been decreasing by -50.46% on average per year.

EPS 1Y (TTM)98.38%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%104.08%

Revenue 1Y (TTM)-66.94%

Revenue growth 3YN/A

Revenue growth 5Y-50.46%

Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

GENX does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

GENIX PHARMACEUTICALS CORP

TSX-V:GENX (4/24/2025, 7:00:00 PM)

0.03

-0.01 (-14.29%)

Chartmill FA Rating

GICS SectorConsumer Staples

GICS IndustryGroupHousehold & Personal Products

GICS IndustryPersonal Care Products

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners19.24%

Ins Owner ChangeN/A

Market Cap1.78M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	433.32
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)0

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)0

FCFYN/A

OCF(TTM)0

OCFYN/A

SpS0

BVpS-0.02

TBVpS-0.02

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-160.53%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	31.71%
FCFM	N/A

ROA(3y)-717.5%

ROA(5y)-440.12%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.09

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.03
Quick Ratio	0.03
Altman-Z	-382.04

F-Score4

WACC6.12%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)98.38%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%104.08%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-66.94%

Revenue growth 3YN/A

Revenue growth 5Y-50.46%

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y72.55%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y15.13%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y15.13%

OCF growth 3YN/A

OCF growth 5YN/A

GENIX PHARMACEUTICALS CORP (GENX.CA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens